Renal dysfunction is relatively common in patients with primary hypertension (PH). a reduction in coronary vasodilator capacity has recently been reported in patients with renal damage undergoing coronary angiography. We investigated the relationship between coronary flow reserve (CFR) and early renal abnormalities in patients with PH and normal serum creatinine.
Chronic kidney disease (CKD), defined as a glomerular filtration rate (GFR) <60 ml/min/1.73 m 2 and/or the presence of microalbuminuria, is a relatively common finding in patients with long-standing primary hypertension (PH), and ranges from 10 to 40% in various studies. 1, 2 This condition is strongly associated with an increased risk of cardiovascular events 3, 4 and represents a potent predictor of unfavorable outcome. 5 Furthermore, there is increasing recognition that patients with coronary artery disease and CKD of any degree have a significantly worse prognosis as compared to those with normal renal function. 6 Recently, decreased coronary flow reserve (CFR) has been demonstrated by intravascular US Doppler in asymptomatic patients with diabetic nephropathy. 7 Moreover, Chade et al. 8 reported a correlation between estimated GFR (eGFR) and CFR in a group of 605 patients with nonobstructive coronary artery disease.
The noninvasive approach of trans-thoracic Doppler echocardiography to assess CFR has allowed to demonstrate that the coronary vasodilator capacity of patients with PH begins to deteriorate very early, due to either the increase in afterload or the abnormalities of the left ventricular (LV) structure and function. 9 In fact, altered CFR has been found in hypertensive patients 10 with several comorbid conditions such as diabetes, 7 dyslipidemia, 11 and extracardiac atherosclerotic changes. 12 However, the relationship between functional and/or structural abnormalities in the coronary bed and renal function has never been examined in a population of hypertensive patients with no clinical indications for cardiac diagnostic procedures. The present study was therefore designed to investigate the relationship between early renal abnormalities and CFR in untreated, nondiabetic, hypertensive patients free of clinical signs of coronary heart disease and with normal creatinine values.
Methods

Patients.
A total of 76 consecutive, untreated patients with PH attending the outpatient clinic of our institution were included in the present study. Hypertension was defined according to standard criteria as clinic systolic blood pressure (BP) ≥140 mm Hg or diastolic BP ≥90 mm Hg on at least two articles Coronary Flow Reserve and Renal Dysfunction different occasions prior to the study day. Exclusion criteria were the presence of neoplastic or hepatic disease, serum creatinine ≥1.3 mg/dl in males and ≥1.2 mg/dl in females, overt proteinuria, secondary hypertension, chronic heart failure (New York Heart Association classes III and IV), a positive history or clinical signs of ischemic heart disease, use of cardioactive medications, diabetes mellitus, severe obesity (defined as body weight > 150% of ideal body weight), disabling diseases such as dementia or the inability to cooperate, and inadequate echocardiographic quality. After obtaining written informed consent, all patients underwent the following procedures: (i) office BP measurement; (ii) blood and urine sampling and echocardiographic examinations including CFR evaluation. The study protocol was approved by the ethical committee of our department.
Recruitment took place between January 2004 and January 2007. Out of 130 untreated hypertensive patients consecutively seen at our clinic within the above-mentioned time range, 91 (all Caucasian Europeans) fulfilled the inclusion criteria. Of the eligible patients, seven did not meet study criteria based on the results of additional tests prescribed for clinical reasons during their first visit to our clinic and eight were excluded because of unwillingness to participate. None of the 76 participating patients were on medication at the time of the study, they had either never been previously treated for hypertension (n = 68, 89%), or had received some antihypertensive treatment in the past (n =8, 11%), albeit intermittently and not during the 6 months prior to the study.
BP was measured by a trained nurse in the nondominant arm, with the patient in the sitting position after a 5-min rest, using a mercury sphygmomanometer (cuff size 12.5 × 40 cm). The systolic and diastolic BPs were read to the nearest 2 mm Hg. The disappearance of Korotkoff sounds (phase 5) was the criterion for diastolic BP. On the study day, three consecutive readings were performed and the average was recorded. Low-density lipoprotein-cholesterol was calculated using Friedewald's formula. 13 Body mass index was calculated by the formula: weight (kg)/height 2 (m 2 ).
Renal studies GFR: Serum creatinine was measured with the modified kinetic Jaffe reaction. GFR was estimated using the CockroftGault formula 14 and normalized for body surface area. Ideal body weight was used in the formula.
Albuminuria: Albuminuria was evaluated by measuring the urinary albumin to urinary creatinine ratio (ACR). The mean of three nonconsecutive first morning samples was recorded. Only samples from patients with negative urine cultures were collected. The urine albumin concentration was measured using a commercially available radioimmunoassay kit (Pantec, Torino, Italy). Microalbuminuria was defined as an ACR of 2.5 mg/mmol or greater in men and an ACR of 3.5 mg/mmol or greater in women. 15 CKD was defined, on the basis of the National Kidney Foundation recommendations 3 as an eGFR <60 ml/min/1.73m 2 and/or the presence of microalbuminuria.
Cardiac studies
Standard echocardiographic examination: All echocardiographic studies were performed using a C256-Acuson Sequoia ultrasound unit (Acuson, Mountain View, CA). The overall mono-dimensional LV measurements and the bi-dimensional (apical, four, and two chamber) views were obtained according to the recommendations of the American Society of Echocardiography. 16 All tracings were obtained and read by a single observer blinded to the clinical characteristics of the patients under observation.
Relative wall thickness (RWT) was determined as the ratio of the sum of septal (inter-ventricular septal thickness) and posterior wall thickness to LV internal end-diastolic diameter. The LV mass was normalized (LV mass index (LVMI)) for height to the 2.7 power. 17 The LV systolic function was evaluated as midwall (epicardial) fractional shortening (MFS). 18 The presence of LV hypertrophy (LVH) was defined as LVMI > 49.2 g/m 2.7 in men and > 46.7 g/m 2.7 in women. 17 Left atrial volume was measured by the area length method using the apical four-chamber (A4Ch, A 1 ) and apical two-chamber (A2Ch, A 2 ) views at ventricular end-systole (maximum LA size). The length (L) is measured from the back wall to the line across the hinge points of the mitral valve. The shorter L, i.e., from either the A4Ch or A2Ch is used in the equation 19 CFR evaluation: Doppler Colour image was used to sample the flow in the distal left anterior descending artery using pulse wave Doppler at a gate size of 2.5-3.0, associated with the infusion of an ultrasound contrast agent (Sonovue, Bracco, Italy) at 1 ml/min to achieve optimal Doppler signal. The intravenous adenosine infusion (140 mcg/kg/min) was started using a separate intravenous line and continued until the fifth minute of infusion. The Doppler baseline coronary spectra as well the peak stress imaging were digitally stored for further analysis. A single experienced operator with no knowledge of the clinical data calculated both the CFR in the left anterior descending artery and the ratio between hyperemic (fifth minute adenosine infusion) and resting peak flow velocities; the mean of three cycles was averaged for each variable. A value <2.0 was considered as impaired CFR. 7, [20] [21] [22] [23] All patients had continuous heart rate and electrocardiogram monitoring, as well as BP recording at baseline, during adenosine infusion and at recovery. None of the patients developed severe adverse effects, such as hypotension, atrioventricular block, or chest pain, during adenosine administration. Beverages containing methylxanthine substances (e.g., coke, tea, and coffee) were not allowed for 24 h before the study. All patients completed the study having echocardiographic examinations of good technical quality. The reproducibility of CFR measurements was determined in a subset of patients (n = 10). Intraobserver variability of CFR determination was assessed as the mean percentage error, calculated by dividing the absolute difference between each pair of CFR determinations by their mean. The intraobserver variability in the determination of CFR was 1.8%. Statistical analysis. Data are expressed as mean ± s.d., except for the duration of hypertension, and high sensitive C-reactive protein which are expressed as median and interquartile ranges. Categorical variables are expressed as proportions. Variables found to deviate from normality were log-transformed (Log) before statistical analysis was carried out. Relations among variables were assessed by using linear regression analysis and the Pearson correlation coefficient. Comparisons between groups were made by the t-test. Comparison of proportion among groups was performed by using the χ 2 -test. Analysis of covariance was used to rule out the effect of several confounders on CFR. Logistic regression analysis was performed to obtain odds ratios and 95% confidence intervals for the risk of having impaired CFR in the presence of CKD. Statistical analyses were performed using Statview for Windows, version 5.0.1 (SAS Institute, Cary, NC). P < 0.05 was considered statistically significant.
results
The main clinical characteristics of our study patients (56 men, 20 women) are reported in Table 1 . The average eGFR was 88 ± 19 ml/min/1.73 m 2 and the prevalence of microalbuminuria, reduced eGFR, CKD, and LVH was 10, 8, 16, and 31%, respectively. Overall, 10% of patients showed impaired CFR.
Univariate analysis showed that urinary albumin excretion was positively related to several variables such as office systolic BP (r = 0.33, P < 0.01) and pulse pressure levels (r = 0.23, P < 0.01), inter-ventricular septal thickness (r = 0.56, P < 0.001), posterior wall thickness (r = 0.46, P < 0.001), RWT (r = 0.37, P = 0.001), LVMI (r = 0.40, P < 0.001), and inversely related to MFS (r = −0.39, P < 0.001) and the CFR/LVMI ratio (r = −0.40, P < 0.001); eGFR was inversely related exclusively to age (r = −0.60, P < 0.001).
We further analyzed our patients' characteristics on the basis of the presence/absence of CKD. Despite similar body mass index, metabolic profile, signs of subclinical inflammation, and office BP levels, patients with abnormal renal function were more likely to be older and of female gender. Patients with CKD showed lower MFS and higher inter-ventricular septal thickness, posterior wall thickness, and RWT ( Table 2) . Moreover, they had significantly higher LVMI, lower CFR and lower CFR/LVMI than patients with normal renal function (Figure 1) . CFR was lower in the group of patients with renal damage, even after adjusting for age, MFS, and RWT (analysis of covariance, P < 0.05).
Patients with impaired CFR showed a significantly higher prevalence of eGFR <60 ml/min (χ 2 5.2, P < 0.05), (Figure 2) . Logistic regression analysis showed that even after adjusting for gender, the presence of renal abnormalities entails a 6.9 times higher risk of having impaired CFR (confidence interval 1.17-40.9, P < 0.05), moreover it entails a 6.4 and 10 times higher risk when adjusted for age or BP load, respectively (confidence interval 1.05-38.76, P < 0.05; 1.37-73.89, P < 0.001). Conversely, probably due to the small sample size of the study group, by simultaneously including gender, age, and BP in the model, we were unable to find an independent correlation between the presence of CKD and impaired CFR.
discussion
The present study demonstrates an association between the presence of CKD and impaired CFR in a group of untreated hypertensive patients with normal serum creatinine and no clinical signs of coronary artery disease in the absence of diabetes. Patients with microalbuminuria and/or a moderate reduction of GFR showed significantly lower coronary flow velocity after adenosine challenge.
By means of trans-thoracic Doppler echocardiography, several studies have shown that in the presence of traditional risk factors such as smoking, 24 hypercholesterolemia, 11 prehypertension, hypertension, 25 and unfavorable LV geometry, 26 CFR may already be impaired even in the absence of significant epicardial coronary stenosis. Moreover, a relatively high prevalence of CFR abnormalities has been described in two preliminary studies that were conducted on a very small sample group of hemodialysis patients 27 and kidney transplant recipients. 28 To the best of our knowledge, this is the first report of an association between the two components of renal dysfunction, i.e., albuminuria and GFR, and impaired coronary reserve in hypertensive patients. Our study integrates and extends previous reports 1, 21, 29 which showed an association between cardiac and renal abnormalities in patients with PH ( Figure 1 and Table 2 ). Moreover, like previous findings in the hypertensive setting, 11 our patients with CKD did not show abnormal coronary flow at rest, indicating that decreased CFR was solely the consequence of reduced vasodilator response ( Table 2 ). There are several mechanisms which may explain impaired hyperemic stimulation of coronary blood flow in patients without coronary heart disease, and they include diffuse but undetectable coronary arteriosclerosis, reduced coronary microvascular bed, and impaired endothelial function.
While LV concentric remodeling and hypertrophy have been associated with CFR impairment, 30 physiologic LVH is usually characterized by a favorable microvascular pattern, resulting in an increase in CFR. 9 Thus, in the context of hypertensive LVH, when baseline coronary flow velocity is already increased due to greater myocardial oxygen consumption, 30 pharmacologically induced hyperemia brings about a reduction in blood flow because of functional and anatomical abnormalities in the coronary microcirculation. These functional abnormalities are made even worse by an increase in LVMI, and by indexing CFR for LVMI we tried to account for these pathophysiologic phenomena with a single parameter. The CFR to LVMI ratio shows a strong, inverse correlation with ACR and is significantly lower in patients with CKD as compared to those with normal renal function (Figure 1) . This parameter could be helpful both in clinical practice to distinguish between physiological and pathological LVH, and when reporting data in order to integrate information on the relationship between LVH and changes in microcirculation.
Analysis of the coronary function of our study population revealed that patients with impaired CFR had a higher prevalence of reduced eGFR and microalbuminuria both when evaluated separately or together as compared to patients with normal vasodilator response (Figure 2) . Moreover, we found that the presence of CKD entails a 10-fold higher risk of having CFR <2.0. A number of possible explanations could account for our findings. The presence of renal abnormalities, be it albuminuria or a reduction in eGFR, may be associated with more severe BP load, metabolic disorders and/or other traditional cardiovascular risk factors. As a matter of fact, our patients with renal damage showed longer duration of hypertension and higher systolic and pulse pressure levels; however, these differences did not reach statistical significance, possibly because our sample size was not powered to detect such a difference in these parameters.
Moreover, albeit patients with renal abnormalities were older, the relationship between renal and cardiac dysfunction held true even after taking age into consideration by means of analysis of covariance. The association we found between female gender and renal abnormalities ( Table 1) is consistent with previous observations that women in general have a higher incidence of small vessel disease including coronary and renal circulation abnormalities. 8, 31, 32 However, logistic regression analysis suggests that the relationship between signs of renal dysfunction and impaired CFR might be independent even after taking gender into consideration.
CFR abnormalities have proven to be of prognostic significance. 23 Previous studies, as well as our own findings indicate that microvascular function is impaired in patients with renal damage. A reduction in CFR might therefore be seen as a surrogate marker of vascular involvement and, even in the absence of significant epicardial coronary stenosis, could possibly be used as a surrogate endpoint to assess the efficacy of therapy toward cardiovascular risk factors. 33 On the other hand, decreased GFR itself may be a risk factor for the progression of ventricular remodeling and cardiac dysfunction, or may simply be a marker of systemic vascular disease and reflect an underlying systemic pathological process, possibly endothelial dysfunction.
The present report has several limitations due to the crosssectional nature of its design and the relatively small number of patients, therefore our results should be regarded as "hypothesis generating" rather than as "hypothesis testing". A further limitation of our study is the lack of extensive coronary angiographic examination. While we excluded patients with ischemic heart disease on the basis of history or clinical, electrocardiogram and echocardiographic signs, we cannot truly exclude the presence of coronary narrowing which might be the reason for impaired CFR. However, owing to the lack of indications and the invasive nature of the procedure, coronary angiography was not routinely performed in our study patients. Nevertheless, our findings may help explain the link(s) between renal and cardiac involvement in patients with hypertension. Indeed, the association between CKD and decreased coronary vasodilator reserve may reflect one or more unmeasured risk factor(s) associated with blunted renal function and thus imply common pathogenetic mechanism(s) underlying changes in both renal and cardiac microcirculation. Moreover, the presence of abnormal flow reserve in patients with hypertension and CKD suggests that it may be a mechanism involved in the excessive cardiovascular mortality rate observed in these patients. 
